LPL Financial LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$17,000
-5.6%
11,700
-2.5%
0.00%
Q4 2016$18,000
-18.2%
12,0000.0%0.00%
Q3 2016$22,000
-18.5%
12,000
-27.5%
0.00%
Q2 2016$27,000
-79.4%
16,550
-75.6%
0.00%
Q1 2016$131,000
+12.0%
67,700
+8.0%
0.00%
Q4 2015$117,000
+34.5%
62,700
+54.6%
0.00%
Q3 2015$87,000
-65.5%
40,550
-27.2%
0.00%
-100.0%
Q2 2015$252,000
-1.6%
55,700
-6.3%
0.00%0.0%
Q1 2015$256,000
+18.0%
59,450
-4.9%
0.00%0.0%
Q4 2014$217,000
-34.2%
62,534
-22.5%
0.00%
-50.0%
Q3 2014$330,000
-28.3%
80,684
+2.8%
0.00%
-33.3%
Q2 2014$460,000
-15.0%
78,500
-8.7%
0.00%0.0%
Q1 2014$541,000
+10.2%
85,950
+2.4%
0.00%0.0%
Q4 2013$491,000
-7.9%
83,916
-31.6%
0.00%
-25.0%
Q3 2013$533,000
-39.2%
122,700
+7.7%
0.00%
-33.3%
Q2 2013$877,000113,9500.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders